Patent: 9,161,992
✉ Email this page to a colleague
Summary for Patent: 9,161,992
Title: | P97 fragments with transfer activity |
Abstract: | The present invention is related to fragments of human melanotransferrin (p97). In particular, this invention relates to treatment of diseases through the introduction of the melanotransferrin fragment conjugated to a therapeutic or diagnostic agent to a subject. |
Inventor(s): | Jefferies; Wilfred (South Surrey, CA), Tian; Mei Mei (Coquitlam, CA), Vitalis; Timothy (Vancouver, CA) |
Assignee: | biOasis Technologies, Inc. (British Columbia, CA) |
Application Number: | 14/226,506 |
Patent Claims: | see list of patent claims |
Details for Patent 9,161,992
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2031-08-05 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2031-08-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2031-08-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2031-08-05 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2031-08-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |